Morning Social Media Outlook for Thursday Feb 23 (VVUS, INTU, DELL, HPQ)

In recent years, traders and investors have increasingly turned to social media to discuss their investments. Now, interested parties can get a scientific look at what is being discussed on a weekly, monthly, and even hourly basis.

Provided by Social Market Analytics, here is the morning social media outlook for Wednesday, February 22.

Most Bullish

Sentiment has been most bullish this morning on a pharmaceutical company and a software developer.

Vivus (NASDAQ: VVUS) has rallied over 100% thus far today. Yesterday, after-hours, an FDA panel voted 20-2 for the company's weight loss drug.

Intuit (NASDAQ: INTU) reported very good earnings two days ago. Yesterday, several analysts boosted their price target on the stock.

Most Bearish

Dell (NASDAQ: DELL) reported poor earnings on Tuesday, and traded lower after the report. Sentiment may still be neutral as competitor HP mimicked much of what Dell said in its earnings call yesterday afternoon.

Hewlett-Packard (NYSE: HPQ) reported disappointing earnings Wednesday after the close, and its stock has traded lower on the session.

Most Discussed

Vivus displaced Apple for the top spot. A doubling of share price in a single session is clearly enough to drive discussion of a stock.

Apple (NASDAQ: AAPL) has had the top spot the previous two days. At 1pm, Apple's new CEO Tim Cook will lead Apple's shareholder meeting.

Hewlett-Packard--beyond its earnings report, CEO Meg Whitman appeared on CNBC this morning to give further color on the state of the company.

Netflix (NASDAQ: NFLX) remains a popular stock to discuss. Comcast's announcement that it would be competing with Netflix may continue to be driving the discussion.

Google (NASDAQ: GOOG) appears on the list for the third time in a row. The report that Google is working to develop digital glasses continues to make its rounds in various media outlets.

Interested in getting more information about stock trends on social media? Signup for the Social Market Analytics newsletter on their website.

(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.